Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElecosoft Regulatory News (ELCO)

Share Price Information for Elecosoft (ELCO)

Share Price is delayed by 15 minutes
Get Live Data
127.50    -2.50 (-1.92%)
Bid:
125.00
Ask:
130.00
Spread: 5.00 (4.00%)
Market Cap: £106.44m
ELCO Live PriceLast checked at - London Stock Exchange

Intraday Elecosoft Share Chart

Notification to Shareholders

21 Mar 2016 07:00

RNS Number : 6979S
Elecosoft PLC
21 March 2016
 

 

21 March 2016

Elecosoft plc

("Elecosoft" or the "Company")

Notification to Shareholders in accordance with FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland"

Adoption of Financial Reporting Standard (FRS) 102 for parent company financial statements

 

Following the publication of FRS 100 Application of Financial Reporting Requirements by the Financial Reporting Council (FRC), Elecosoft plc is required to change the accounting framework for its parent entity financial statements and those of its subsidiaries, which have up until now adopted UK Generally Accepted Accounting Practice (UK GAAP).

 

The consolidated financial statements of the Group are and will continue to be prepared in accordance with International Financial Reporting Standards (IFRS), and no changes are required. For the individual accounts of the parent entity and its UK subsidiaries, the Board considers that it is in the best interests of the Group to adopt FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".

 

The Company's decision to adopt FRS 102 for its parent entity financial statements and those of its UK subsidiaries does not require shareholder approval. However, due to the election to take the disclosure exemptions permitted under FRS 102, the Company is required to notify all shareholders of this election. No disclosures in the previous UK GAAP financial statements would be omitted on adoption of the disclosure exemptions under FRS 102.

 

Any shareholder or shareholders holding in aggregate 5 per cent or more of the total allotted shares in the Company may object. Objections must be served in writing and delivered to the Company Secretary at the Company's registered office at 66 Clifton Street, London, EC2A 4HB not later than 4 April 2016.

 

This notification will apply on an ongoing basis until such time as the Company notifies its shareholders of any change to its chosen accounting framework for the parent company financial statements.

 

For further information please contact:

 

Elecosoft plc

JHB Ketteley , Executive Chairman

 

www.eleco.com

Tel: 0207 422 0044

Nick Caw, Chief Executive Officer

 

finnCap Ltd

Geoff Nash / Kate Bannatyne (Corporate Finance)

Malar Velaigam (Corporate Broking)

Tel: 0207 220 0500

 

Redleaf Communications

Rebecca Sanders-Hewett / David Ison

/ Susie Hudson

Tel: 0207 382 4730

elecosoft@redleafpr.com

 

About Elecosoft plc

Elecosoft plc specialises in the development and delivery of integrated software and services solutions to the global Architectural, Engineering and Construction industry. Their solutions cover the full project lifecycle with offerings that help bring together project management, construction, timber engineering, design, 3D visualisation and marketing communities.

The Group operates principally in Sweden, Germany, the UK and increasingly in other markets worldwide.

Elecosoft plc is listed on the Alternative Investment Market in London (AIM: ELCO).

For more information please visit www.elecosoft.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUASNRNRAOURR
Date   Source Headline
2nd Aug 20187:00 amRNSTrading Update
5th Jul 20187:00 amRNSAcquisition of Shire Systems Limited
14th Jun 20187:00 amRNSResult of Scrip Dividend
6th Jun 20187:00 amRNSAppointment of Corporate Development Director
17th May 20182:30 pmRNSResults of AGM
17th May 20187:00 amRNSTrading Update
20th Apr 20187:00 amRNSNotice of AGM
27th Mar 20187:00 amRNSPreliminary Results
21st Mar 20187:00 amRNSNotice of Results
5th Mar 20187:00 amRNSExhibiting at the Master Investor Show 2018
8th Feb 20187:00 amRNSIssue of Options
5th Feb 20187:50 amRNSAppointment of Non-Executive Director
23rd Jan 20187:00 amRNSTrading Statement
22nd Dec 20177:00 amRNSDirectorate Change
7th Dec 20177:00 amRNSCollaboration Agreement
20th Nov 20179:30 amRNSDouble Award Win
15th Nov 20177:00 amRNSAppointment of Finance Director
10th Nov 20177:00 amRNSTotal Voting Rights & Director/PDMR Shareholding
8th Nov 20177:00 amRNSDirector Dealing
6th Nov 20174:03 pmRNSResult of Scrip Dividend - Replacement
6th Nov 20177:00 amRNSResult of Scrip Dividend
25th Sep 20177:00 amRNSChange of Registered Office
25th Sep 20177:00 amRNSInterim Results
18th Sep 20177:00 amRNSNotice of Results
21st Aug 20177:00 amRNSDirectorate Change
10th Aug 20172:32 pmRNSReplacement: Issue of Options
10th Aug 20177:00 amRNSIssue of Options
7th Aug 20177:00 amRNSAmendment to Result of Scrip Dividend
17th Jul 20177:22 amRNSTrading Update
25th May 20177:25 amRNSResult of Scrip Dividend
4th May 20174:45 pmRNSResult of AGM
4th May 201712:03 pmRNSAppointment of Non Executive Deputy Chairman
4th May 201712:00 pmRNSTrading Update
10th Apr 20177:00 amRNSNotice of AGM and posting of Report & Accounts
27th Mar 20177:00 amRNSPreliminary Results
27th Mar 20177:00 amRNSDirectorate Appointments
20th Mar 20171:19 pmRNSNotice of Results
30th Jan 20177:00 amRNSDirectorate Appointment
20th Jan 20177:00 amRNSTrading Statement
6th Jan 20177:00 amRNSDirectorate Change
20th Dec 20164:22 pmRNSDirector Dealing
14th Nov 201612:55 pmRNSChange of Registered Office
28th Oct 20169:26 amRNSIssue of Options
24th Oct 20165:01 pmRNSHolding(s) in Company
17th Oct 20164:52 pmRNSChange of Registered Office
17th Oct 20167:00 amRNSAcquisition of ICON
21st Sep 20167:00 amRNSInterim Results
14th Jun 20167:00 amRNSBoard Appointment
26th May 20163:28 pmRNSResult of AGM
26th May 201612:00 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.